An interventional study of point-of-care milk sodium testing in Breastfeeding, Preterm Birth and Breast Pumping, sponsored by The Hospital for Sick Children. Active, not recruiting at 2 sites in United States. Open to female participants. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by The Hospital for Sick Children · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Breast Milk Expression with a site in United States — 6 open to participants now, 10 under way, none of them phase 3. Breast Milk Expression · United States.
Among the 32 studies in Breast Milk Expression with a site in United States, this one is the 15th largest by planned enrollment of the 22 interventional ones that give a count, is one of 5 that started in 2025, is one of 21 with no phase, and was the 27th registered.
88 studies on the registry are indexed under Breast Milk Expression; 19 are open to participants now.
Browse Breast Milk Expression studies →6 of the 32 studies in Breast Milk Expression with a site in United States are open now. Recruiting first, the newest first:
Arkansas Children's Hospital Research Institute · Sites in United States
Ages 18+ · Women only
Mayo Clinic · Sites in United States
Ages 20+ · Women only · Healthy volunteers
Thomas Jefferson University · Sites in United States
Ages 18+ · Women only
University of Alabama at Birmingham · Sites in United States
Ages up to 28 days
Winthrop University · Sites in United States
Ages 18–40 · Women only · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 13 Breast Milk Expression studies recruiting now, 6 (46%) set no upper age limit and 7 (54%) stop at 75 or younger; 3 take children under 18; 10 take healthy volunteers.
This study: female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 60 across 49 interventional studies indexed under Breast Milk Expression.
Median enrollment 52 across the 22 interventional studies, 30 across the 10 observational. Of the 16 that completed or were terminated, 2 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 32 have an industry lead sponsor. The 10 most frequent:
The Hospital for Sick Children is the lead sponsor of 579 studies on the registry; 81 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
The Hospital for Sick Children has 2 studies filed under Breast Milk Expression — fewer than ten, so there is no comparison to draw.
2 of the studies in Breast Milk Expression with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03977259Brigham and Women's HospitalTargeting Human Milk Fortification to Improve Preterm Infant Growth and Brain Development | 2027-08-31 |
| NCT06673160University of Alabama at BirminghamPumping to Up Maternal Milk Production for Preterms | 2027-09 |
Add all 2 to your calendar (.ics) → With an account.
Among the 32 studies in Breast Milk Expression with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
SALT is a multi-centre, non-blinded, non-randomized prospective interventional pilot study teaching lactating parents of hospitalized preterm infants how to test their breastmilk sodium (Na) using point-of-care (POC) meters. A drop in Na is a sign of secretory activation in the breast that is associated with adequate short and long-term breast milk volumes in this vulnerable population.
Primary Objective: Establish feasibility, acceptance, and time cost of parent-led parent milk Na testing in the first 14 days postpartum
Secondary Objective: Further investigate relationships between pumping behaviours, lactation risk factors, daily milk Na and lactation outcomes
Exploratory Objective: Explore how POC Na data may be used to modify pumping behaviour and milk volumes
88 studies on the registry are indexed under Breast Milk Expression; 19 are open to participants now.
This study's planned enrollment of 40 is below the median of 60 across 49 interventional studies indexed under Breast Milk Expression.
Browse Breast Milk Expression studies →The Hospital for Sick Children is the lead sponsor of 579 studies on the registry; 81 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
Compared within Breast Milk Expression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Breast Feeding. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Data-driven interventions to improve early lactation success are lacking, and parents who deliver preterm are at high risk of lactation challenges. We will be studying feasibility, acceptability, and time cost of teaching lactating parents of hospitalized preterm infants how to test their breastmilk sodium (Na) using point-of-care (POC) meters. As a secondary aim, we will assess the potential to use these POC sodium results to guide personalized lactation care in the form of altered pumping schedules in an attempt to reduce breastmilk Na. A drop in Na is a sign of secretory activation in the breast that is associated with adequate short and long-term breast milk volumes in this vulnerable population.
Establish feasibility of parent-led longitudinal parent milk Na testing in the first 14 days postpartum: economic
We will collect time cost of milk testing, including teaching parents how to test milk and daily time testing milk. This outcome will include time (in hours) spent in the first 14 days for parent and staff, with a health economist determining costs for that time
Time frame: First 14 days postpartum
Establish feasibility of parent-led longitudinal parent milk Na testing in the first 14 days postpartum: parent acceptance via interviews
We will collect qualitative data on parent acceptance and feelings about Na testing from parent interviews
Time frame: First 14 days postpartum
Establish feasibility of parent-led longitudinal parent milk Na testing in the first 14 days postpartum: parent acceptance via surveys
We will collect qualitative data on parent acceptance and feelings about Na testing from parent surveys
Time frame: First 14 days postpartum
Investigate inter-relationships between pumping frequency, parent lactation risk factors, daily milk Na levels and longer term lactation outcomes (milk provision at NICU discharge).
We will assess interrelationships between aforementioned factors and milk provision at NICU discharge (exclusive, any, none). Note these are not necessarily correlations, but relationships and associations that we will analyze and explore in various models and combinations, so these outcome cannot be separated.
Time frame: Enrollment to infant NICU discharge, up to 52 weeks (average NICU stay is about 10 weeks)
Investigate inter-relationships between pumping frequency, parent lactation risk factors, daily milk Na and short term lactation outcomes (coming to volume)
We will assess interrelationships between aforementioned factors and coming to volume (pumping at least 500mL/day by postpartum day 14).Note these are not necessarily correlations, but relationships and associations that we will analyze and explore in various models and combinations, so these outcomes cannot be separated.
Time frame: First 14 days postpartum
Explore if POC Na data used to recommend changes in pumping behaviour is associated with actual changes in parent pumping behaviour
Explore in parents whom we recommend to modify pumping frequency, rates of coming to volume by day 14 (pumping at least 500mL/day)
Time frame: First 14 days postpartum
Explore how POC Na data used to recommend changes in pumping behaviour is associated with short-term milk volumes
Determine in parents whom we recommend to modify pumping frequency based on POC Na, how often they actually followed our recommendations
Time frame: First 14 days postpartum
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Mar 2025 to primary completion in Jan 2026, 9 months.
Of 32 non-industry interventional studies with no phase under Breast Milk Expression, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 28. This study's 9 months is below that.
Counting every sponsor, half of 39 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Dec 2025 → Jan 2026 and completion Mar 2026 → Mar 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Hospital for Sick Children →